Ma et al.36 also reported miR-3613-5p as a prognostic biomarker for pancreatic carcinoma and found that the target genes of miR-3613-5p might be correlated with the p53 signaling pathway. The gene discussed is TP53; the disease is exocrine pancreatic carcinoma.